Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

ORGANOIDS

An in vitro model of myocardial infarction

Nature Biomedical Engineering volume 4, pages 366–367 (2020)Cite this article

Subjects

Structural and functional changes following infarction in a human heart can be modelled with human cardiac organoids set in a hypoxic gradient and stimulated with the neurotransmitter noradrenaline.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Human cardiac organoids as models of myocardial infarction.

References

  1. Mills, R. J. & Hudson, J. E. APL Bioeng. 3, 010901 (2019).

    Article  Google Scholar 

  2. Mannhardt, I. et al. Stem Cell Rep. 7, 29–42 (2016).

    Article  CAS  Google Scholar 

  3. Hinson, J. T. et al. Science 349, 982–986 (2015).

    Article  CAS  Google Scholar 

  4. Tiburcy, M. et al. Circulation 135, 1832–1847 (2017).

    Article  CAS  Google Scholar 

  5. Giacomelli, E. et al. Development 144, 1008–1017 (2017).

    Article  CAS  Google Scholar 

  6. Voges, H. K. et al. Development 144, 1118–1127 (2017).

    Article  CAS  Google Scholar 

  7. Mills, R. J. et al. Proc. Natl Acad. Sci. USA 114, e8372–e8381 (2017).

    Article  CAS  Google Scholar 

  8. Mills, R. J. et al. Cell Stem Cell 24, 895–907.e6 (2019).

    Article  CAS  Google Scholar 

  9. Richards, D. J. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0539-4 (2020).

    Article  Google Scholar 

  10. Hesse, A. R. et al. Cell. Physiol. Biochem. 34, 455–462 (2014).

    Article  CAS  Google Scholar 

  11. Stratton, M. S. et al. Circ. Res. 125, 662–677 (2019).

    Article  CAS  Google Scholar 

  12. Arevalo, H. J. et al. Nat. Commun. 7, 11437 (2016).

    Article  CAS  Google Scholar 

  13. Farbehi, N. et al. eLife 8, e43882 (2019).

    Article  Google Scholar 

  14. Chouchani, E. T. et al. Nature 515, 431–435 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

    Richard Mills & James Hudson

Authors
  1. Richard Mills
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Hudson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Hudson.

Ethics declarations

Competing interests

R.M. and J.H. have collaborated with AstraZeneca for the discovery of new heart-failure drugs, are on the scientific advisory board of Dynomics for the discovery of new heart-failure drugs, and have patents related to bioengineered-tissue technologies and culture conditions, and to putative therapeutic targets for heart failure.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mills, R., Hudson, J. An in vitro model of myocardial infarction. Nat Biomed Eng 4, 366–367 (2020). https://doi.org/10.1038/s41551-020-0550-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-020-0550-9

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research